Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Gastrointestinal 1CNS 1

Conditions

Glioblastoma 14Brain Neoplasms 12Glioma 11Astrocytoma 9Meningioma 7Central Nervous System Neoplasms 7Gliosarcoma 6Diffuse Intrinsic Pontine Glioma 6Recurrence 4Neurofibromatosis 2 4Tuberous Sclerosis 3Pheochromocytoma 3Paraganglioma 3Neuroma, Acoustic 3Rhabdomyosarcoma 2Oligodendroglioma 2Neurofibromatosis 1 2Neuroendocrine Tumors 2Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2von Hippel-Lindau Disease 1Zollinger-Ellison Syndrome 1Vestibulocochlear Nerve Diseases 1Tuberous Sclerosis 2 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Seizures 1Sarcoma 1Salivary Gland Neoplasms 1

Interventions

Docetaxel 6Radiotherapy 5Filgrastim 3Erlotinib Hydrochloride 3Cetuximab 3Capecitabine 3Bevacizumab 3entrectinib 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Gemcitabine 2Fluorodeoxyglucose F18 2Cisplatin 2Chemotherapy, Adjuvant 2Acupuncture Therapy 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1tanespimycin 1spartalizumab 1sargramostim 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1cevimeline 1alectinib 1aldesleukin 1X-Ray Therapy 1Vorinostat 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × Everolimus × CNS × Clear all
NCT01637194 2012-07-11

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

Fox Chase Cancer Center

Phase 1 Completed
12 enrolled
CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡